SCHEMBL7780799

SCHEMBL7780799

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)nn(C)c2C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.60
PTGS1 P23219 8/20 0.60
CA2 P00918 5/20 0.54
CA9 Q16790 5/20 0.54
CA1 P00915 4/20 0.54
CA12 O43570 4/20 0.54
PDPK1 O15530 3/20 0.54
CA4 P22748 2/20 0.54
CA3 P07451 2/20 0.54
CA6 P23280 2/20 0.54
CA5A P35218 2/20 0.54
CA7 P43166 2/20 0.54
CA5B Q9Y2D0 2/20 0.54
PTGES O14684 1/20 0.54
HDAC3 O15379 1/20 0.54
PDE5A O76074 1/20 0.54
ABCB11 O95342 1/20 0.54
MT-CO2 P00403 1/20 0.54
LMNA P02545 1/20 0.54
CYP3A4 P08684 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780051 0.90 PTGS2 (0.60) PTGS2PTGS1CA2CA9CA1
SCHEMBL7780017 0.90 PTGS2 (0.73) PTGS2PTGS1CA2CA9CA1
SCHEMBL7780485 0.89 PTGS2 (0.58) PTGS2PTGS1CA2CA9CA1
SCHEMBL7779998 0.89 PTGS2 (0.58) PTGS2PTGS1CA2CA9CA1
SCHEMBL7779376 0.89 PTGS2 (0.59) PTGS2PTGS1CYP2C9
SCHEMBL7779784 0.87 PTGS2 (0.56) PTGS2PTGS1CA2CA9CA1
SCHEMBL7779604 0.87 PTGS2 (0.56) PTGS2PTGS1CA2CA9CA1
SCHEMBL7772816 0.85 PTGS2 (0.54) PTGS2PTGS1CA2CA9CA1
SCHEMBL7779953 0.84 PTGS2 (0.83) PTGS2PTGS1CA2CA9CA1
SCHEMBL7778278 0.83 PTGS2 (0.54) PTGS2PTGS1CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed